DIA 2026 Global Executive Day
This interactive discussion is targeted to CxO-level industry leaders and facilitated by DIA’s knowledge partner, McKinsey & Company. Together, we will explore how shifting market dynamics are reshaping R&D pipelines, portfolio strategy, and innovative operating models, and what it will take to sustain the industry’s value creation engine beyond 2030.
The Future of Life Sciences Innovation Will Be Shaped by the Leaders in the Room.
Your perspective and the perspectives of your peers will drive the conversation.
Opening Plenary and Keynote: Hidden Potential: Turning Today’s Science into Tomorrow’s Cures
Kick off DIA 2026 on Monday morning with a keynote from David Fajgenbaum and a panel on AI in biopharma, the session asks how we can find, trust, and deliver tomorrow’s cures from today’s science.
Break in Exhibit Hall
Explore the latest innovations from leading pharmaceutical and life sciences organizations.
Market Access Executive Session
Presentation by Numerof & Associates
Luncheon
Rewiring the Life Sciences Value Engine
Strategic Responses to Global Innovation, Pricing Pressure, and AI
Presentation by McKinsey & Company
The life sciences value creation model is being fundamentally reshaped. For decades, pharma has delivered sustained patient and shareholder value through US and EU-led innovation economics, competitive therapeutic landscapes, lifecycle expansion, and clinically driven physician adoption.
Today, that model is evolving through a series of structural shifts that create new opportunities: potential MFN policy is prompting a rethink of global launch and pricing strategy; China’s accelerating role in innovation is expanding the global engine of scientific discovery; lifecycle compression is driving earlier value capture and sharper portfolio focus; rising chronic-care demand is catalyzing new access and patient engagement models; and advances in AI and productivity are opening pathways to faster development and more efficient operations.
Wildcard Breakouts
Interactive discussions moderated by McKinsey & Company and other industry leaders.
Example breakout roundtable discussions:
- What if the world stops treating the FDA as the default regulatory gold standard?
- What if the next wave of breakthrough assets disproportionately originates in China?
Break
Wildcard Report Outs
Table facilitators share key takeaways, sparking cross-group dialogue and surfacing the insights that will drive the field forward.
Closing Remarks
A synthesis of the day’s most important conversations and a look ahead at how DIA will carry these insights into action.
Executive Networking Reception
Cap off Global Executive Day by connecting with fellow C-suite peers over cocktails and hors d’oeuvres in a dedicated networking space within The Exchange during the DIA Welcome Reception.
Executive Leadership Across Healthcare
Join fellow C-suite executives and senior leaders from across the pharmaceutical ecosystem.
Celonis
This Event is Invite Only
Interested in joining this exclusive gathering of pharmaceutical leaders?
Learn more about participation